Affordable Access

Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice.

Authors
  • van der Vliet, Hendrik N
  • Schaap, Frank G
  • Levels, Johannes H M
  • Ottenhoff, Roelof
  • Looije, Norbert
  • Wesseling, John G
  • Groen, Albert K
  • Chamuleau, Robert A F M
Type
Published Article
Journal
Biochemical and biophysical research communications
Publication Date
Aug 02, 2002
Volume
295
Issue
5
Pages
1156–1159
Identifiers
PMID: 12135615
Source
Medline
License
Unknown

Abstract

Mice lacking ApoA-V, a novel HDL-associated apolipoprotein identified by our group and independently by Pennacchio et al. [Science 294 (2001) 169], were recently shown to be hypertriglyceridemic. To study the role of ApoA-V in triglyceride homeostasis, we compared lipid profiles in mice expressing normal and highly elevated levels of ApoA-V. For this purpose, adenoviral vectors expressing sense or antisense ApoA-V cDNA were constructed. Treatment of mice with sense adenoviral constructs resulted in circa 20-fold higher serum ApoA-V levels compared with mice injected with either PBS or antisense adenoviral constructs. ApoA-V overexpressing mice had markedly decreased (-70%) serum triglyceride levels caused primarily by lowered triglyceride content of the VLDL fraction. Furthermore, in these mice cholesterol levels were found to be lowered in all lipoprotein fractions with the largest mass decrease in the HDL fraction. This resulted in a 40% drop of serum cholesterol content. These findings suggest a role of ApoA-V in regulating levels of circulating triglycerides and cholesterol.

Report this publication

Statistics

Seen <100 times